McKesson Corporation has completed the acquisition of a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures), a business and administrative services organization established by Florida Cancer Specialists & Research Institute, LLC (FCS). Announced by McKesson on [insert date here], the transaction gives McKesson a 70% controlling interest in Core Ventures for approximately $2.49 billion, while FCS physicians retain a 30% stake. This acquisition aims to enhance community-based oncology care, accelerate clinical development, and expand access to quality cancer care in local communities. FCS, with over 250 physicians and 280 advanced practice providers across nearly 100 locations in Florida, remains independently owned and joins McKesson's The US Oncology Network.